articleTop 1% cited
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
European Journal of Cancer · 2008 · Vol. 45(2) · pp. 228–247
E. Eisenhauer✉(Queen's University)P. Therasse(GlaxoSmithKline (Belgium))Jan Bogaerts(European Organisation for Research and Treatment of Cancer)Lawrence H. Schwartz(Memorial Sloan Kettering Cancer Center)Daniel J. Sargent(Mayo Clinic)Robert C. FordJanet Dancey(National Cancer Institute)Susan G. ArbuckStephen J. Gwyther(East Surrey Hospital)Margaret Mooney(National Cancer Institute)Larry Rubinstein(National Cancer Institute)Lalitha Shankar(National Cancer Institute)Lori E. Dodd(National Cancer Institute)Richard Kaplan(NIHR Clinical Research Network)Denis Lacombe(European Organisation for Research and Treatment of Cancer)Jaco J. Verweij(Erasmus MC)
Radiomics and Machine Learning in Medical ImagingMedical Imaging Techniques and ApplicationsLung Cancer Treatments and MutationsGuidelineResponse Evaluation Criteria in Solid TumorsMedicineClinical trialClinical endpointPathologicalDiseaseTarget lesionProgressive diseaseMedical physics
MeSH terms
Clinical Trials as TopicEuropeHumansLymph NodesMagnetic Resonance ImagingNeoplasmsTomography, X-Ray ComputedTreatment OutcomeDisease Progression
Funding
- Medical Research Council
Citations
28,935
FWCI
215.43
field-weighted impact
References
26
Percentile
100%
vs. same field & year
Citations per year
Cited by
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2018 · 6,460 citations
Use of image registration and fusion algorithms and techniques in radiotherapy: Report of the AAPM Radiation Therapy Committee Task Group No. 132
Medical Physics · 2017 · 812 citations
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Hepatology · 2023 · 1,480 citations
Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
Science Translational Medicine · 2012 · 1,113 citations
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
The Lancet Oncology · 2016 · 1,385 citations
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
New England Journal of Medicine · 2015 · 8,055 citations
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
Oncotarget · 2015 · 324 citations
COSMIC: the Catalogue Of Somatic Mutations In Cancer
Nucleic Acids Research · 2018 · 5,156 citations
References
Response criteria for phase II studies of supratentorial malignant glioma.
Journal of Clinical Oncology · 1990 · 2,400 citations
Revised Response Criteria for Malignant Lymphoma
Journal of Clinical Oncology · 2007 · 4,425 citations
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
JNCI Journal of the National Cancer Institute · 2000 · 15,689 citations
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
Journal of Clinical Oncology · 2008 · 2,225 citations
Reporting results of cancer treatment
Cancer · 1981 · 7,848 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.